Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(20):1639-1640; doi:10.1093/jnci/92.20.1639
© 2000 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 20, 1639-1640, October 18, 2000
© 2000 Oxford University Press


NEWS

Awards, Appointments, Announcements

The Cancer Research Foundation of America’s Congressional Families Action for Cancer Awareness Program, a bipartisan outreach effort by family members of the Senate, House, Cabinet, and Supreme Court to increase cancer awareness, recently honored seven individuals dedicated to its mission:

U.S. Rep. John Porter (R-Ill.) and Sen. Connie Mack (R-Fla.) both received the Lifetime Achievement Award for their significant contributions to cancer legislation and funding for the National Institutes of Health and the National Cancer Institute.

Tamra Bentsen, spouse of Rep. Ken Bentsen (D-Texas), and Jill Biden, spouse of Sen. Joe Biden (D-Del.), were honored with the Spouse Award for their tremendous contributions toward educating constituents about the importance of early detection and prevention of cancer.

• Breast cancer survivors Ruth Ann LaMott and Barbara Raehl received the Advocate Award for their creation of the Navigator Program in the Traverse City, Mich., Munson Medical Center, which helps guide patients after a breast cancer diagnosis.

Shirley Reudy, a health care columnist with Iowa’s Cedar Rapids Gazette and two-time cancer survivor, was recognized with the Media Award for her staunch efforts to spread the message of cancer prevention and education through her writing.

Lippman Going to Michigan

The University of Michigan Medical School, Ann Arbor, has appointed Marc E. Lippman, M.D., to chair its Department of Internal Medicine. His appointment will be effective Feb. 1, 2001.



View larger version (139K):
[in this window]
[in a new window]
 
Dr. Marc E. Lippman

 
He will also hold the title of John G. Searle Professor of Medicine. Lippman goes to the University of Michigan from Georgetown University Medical Center, Washington, D.C., where he heads the Vincent T. Lombardi Cancer Research Center and chairs the Department of Oncology. He is also a professor of medicine and chief of the Division of Hematology-Oncology.

Before arriving at Georgetown in 1988, Lippman headed the Medical Breast Cancer Section of the Medicine Branch of the National Cancer Institute, one of the National Institutes of Health. He is also an associate editor of this Journal.

Waters Named

The Gerald P. Murphy Cancer Foundation, Seattle, appointed David J. Waters, D.V.M., Ph.D., as its executive director.



View larger version (126K):
[in this window]
[in a new window]
 
Dr. David J. Waters

 
Waters focuses on the fields of comparative medicine and prostate cancer research. His commitment to basic, comparative, and clinical research will serve as the backbone of the foundation’s new scientific direction.

The Gerald P. Murphy Cancer Foundation, formerly the Pacific Northwest Cancer Foundation, voted to rename its organization to honor its former director, who died in January. Murphy was also the secretary general of the International Union Against Cancer, Geneva.

Prior to his new appointment, Waters was the co-director of Purdue University’s Comparative Oncology Program; Director of the Drug Development Shared Resource of the Purdue Cancer Center, a core facility for the evaluation of new anti-cancer agents; and Associate Director of the Purdue Gerontology Program.

DCLG Members Named

The National Cancer Institute has announced its intent to appoint five new members to the NCI Director’s Consumer Liaison Group. The new members are:

Barbara LeStage, Wrentham, Mass.—LeStage is a 5-year breast cancer survivor. She has served on a Department of Defense Breast Cancer Research Panel, has worked as a member of the Institutional Research Grant Review Committee at Massachusetts General Hospital, and is serving as a member of the Harvard Center for Cancer Prevention Advisory Board and the Joint Commission on Accreditation of Healthcare Organizations’ Public Advisory Group on Health Care Quality.

Pamela McAllister, Ph.D., Fitchburg, Wis.—McAllister is a 7-year survivor of a rare form of colon cancer. She is chairperson of the Board of Directors of the Colorectal Cancer Network. McAllister is also a founding member of the Colon Cancer Alliance and now serves as a science advisor, interacting with the scientific community on behalf of both the Network and the Alliance. She has served as the patient member of the NCI Colorectal Cancer Progress Review Group and the GI State-of-the-Science Symposium.

Nyrvah Richard, New York, N.Y. —Richard was diagnosed with a rare form of ovarian cancer in 1996. She soon learned that, without health insurance, her treatment options were limited. After chemotherapy, she turned to SHARE: Self Help for Women with Breast or Ovarian Cancer, a New York City-based advocacy group. She became a volunteer for its hotline and served as a support group facilitator. She recently became its director. She is active on SHARE’s Project SOS (SHARE Ovarian Survivorship), a project to educate the medical profession about the issues a woman faces when diagnosed with ovarian cancer.

Henry Porterfield, Hinsdale, Ill.— Porterfield is an 8-year survivor of prostate cancer. He is chair/CEO of US TOO! International Inc. and was a founding member of the National Prostate Cancer Coalition. Porterfield has served on NCI cooperative group committees, the Cancer Leadership Council and various NCI and NIH committees. He has developed cancer survivorship partnerships between US TOO! and the NCI, the Food and Drug Administration, the Veteran’s Administration, and the Centers for Disease Control and Prevention.

Paula Simper, Rancho Palos Verdes, Calif.—Simper is the co-founder, chairwoman, and chief executive officer of the Pancreatic Cancer Action Network Inc. She has a long list of service involvement with the Centinela Hospital Medical Center Trustees Associate Board, the National Cancer Legislative Advisory Committee, the Radiation Therapy Oncology Cooperative Group, and the NCI Pancreatic Cancer Progress Review Group. She is a collaborating partner in the National Dialogue on Cancer.

All DCLG members serve three-year terms. The DCLG makes recommendations to the director of NCI from the consumer advocate perspective on a wide variety of issues, programs, and research priorities. NCI brings together these advocates for regular meetings that create a two-way forum for direct interactions with the scientific community at NCI.

Items in "Awards, Appointments, Announcements" are compiled from notices received by the News section. Not all notices are used; all those used are edited.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?